Alan Rigby Email & Phone

Chief Executive Officer @ Epitopea

President and Chief Executive Officer, Co-Founder, President and Chief Scientific Officer @ HiberCell

President @ Acr Biotechnology Consultants

Co-Founder, President and Chief Scientific Officer @ Hibercell

Senior Board Advisor @ Hibercell

President and Chief Executive Officer @ Hibercell

Chief Scientific Officer @ Warp Drive Bio, Inc.

Chief Scientific Officer, Senior Vice President @ Synta Pharmaceuticals

Vice President of Antibody Drug Conjugate Biology @ Imclone Systems, a Wholly-Owned Subsidiary of Eli Lilly and Company

Vice President Research- Computational Discovery and Chemistry @ Imclone Systems, a Wholly-Owned Subsidiary of Eli Lilly and Company

Adjunct Assistant Professor @ Harvard Medical School

Adjunct Director of Drug Discovery and Target Validation @ Beth Israel Deaconess Medical Center

Co-Founder, Sab Member @ Karyon Therapeutics

Director Program in Drug Discovery and Target Validation @ Beth Israel Deaconess Medical Center

Assistant Professor @ Harvard Medical School

Co-Founder, Consultant @ Vasculomedics

Instructor of Medicine @ Harvard Medical School

1991 - 1995 Doctor of Philosophy @ Western University

Drug Discovery, Oncology, Biochemistry, Life Sciences, Biotechnology, Computational Chemistry, Antibodies, Target Identification, Validation, Academia, Molecular Biology, Biomarker Discovery, Immunology, Chemistry, Structural Biology, NMR, Protein Chemistry, Innovator, Drug Development, Clinical Development, Clinical Trials, Pharmaceutical Industry

Alan Rigby, based in New York, NY, US, is currently a Chief Executive Officer at Epitopea. Alan Rigby brings experience from previous roles at HiberCell, Acr Biotechnology Consultants, Hibercell, Hibercell, Hibercell, Warp Drive Bio, Inc., Synta Pharmaceuticals, Imclone Systems, a Wholly-Owned Subsidiary of Eli Lilly and Company, Imclone Systems, a Wholly-Owned Subsidiary of Eli Lilly and Company, Harvard Medical School, Beth Israel Deaconess Medical Center, Karyon Therapeutics, Beth Israel Deaconess Medical Center, Harvard Medical School, Vasculomedics, Harvard Medical School. Alan Rigby holds various educational qualifications including Doctor of Philosophy in Biochemistry (1991 - 1995) from Western University. With a robust skill set that includes Drug Discovery, Oncology, Biochemistry, Life Sciences, Biotechnology, Alan Rigby demonstrates proficiency in a wide range of areas.